UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 43 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $15,928,000 | +49.7% | 1,835,000 | 0.0% | 0.00% | +33.3% |
| Q1 2020 | $10,643,000 | -19.6% | 1,835,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $13,230,000 | +18.2% | 1,835,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $11,194,000 | -35.8% | 1,835,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $17,433,000 | +17.1% | 1,835,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $14,882,000 | -37.3% | 1,835,000 | +25.6% | 0.00% | -33.3% |
| Q4 2018 | $23,754,000 | +40.9% | 1,460,885 | +41.1% | 0.01% | +50.0% |
| Q3 2018 | $16,860,000 | +410.0% | 1,035,000 | +371.5% | 0.00% | +300.0% |
| Q2 2018 | $3,306,000 | – | 219,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $7,294,000 | 8.07% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,081,000 | 1.01% |
| Founders Fund V Management, LLC | 491,751 | $2,282,000 | 0.78% |
| Tibra Equities Europe Ltd | 80,700 | $374,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 205,882 | $955,000 | 0.11% |
| Hall Private Wealth Advisors | 18,500 | $86,000 | 0.06% |
| 20/20 Capital Management, Inc. | 42,840 | $199,000 | 0.05% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 64,789 | $301,000 | 0.05% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 759,918 | $3,526,000 | 0.02% |
| PDT Partners, LLC | 74,178 | $344,000 | 0.02% |